TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19695853

Group type: EXPERIMENTAL
Intervention: Low-intensity physical activity (Group B)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: High-intensity aerobic exercise (Group C)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Aerobic+resistance exercise (Group D)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Sedentary control (Group A)
Number of subjects: 82
Study: 17378780

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 36
Study: 16278360

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA) of the left atrium during mitral valve surgery
Number of subjects: 97

Group type: COMPARATOR
Intervention: Mitral valve surgery alone (control)
Number of subjects: 97
Study: 12817747

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) with cyclic estrogen and progestogen (norethisterone acetate) for 2 years
Number of subjects: 10
Study: 9895220

Group type: EXPERIMENTAL
Intervention: Age-dependent increases in oxidative damage markers
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Correlation between oxidative damage markers
Number of subjects: 66
Study: 7718368

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: bupivacaine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.25% bupivacaine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ropivacaine and bupivacaine
Number of subjects: 40
Study: 2188408

Group type: EXPERIMENTAL
Intervention: Terbutaline via Turbohaler (powder)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Terbutaline via freon spray (aerosol)
Number of subjects: 140
Study: 6104938

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Meperidine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pentazocine
Number of subjects: 40
Study: 12209433

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 29477138

Group type: EXPERIMENTAL
Intervention: Self-directed yoga practice
Number of subjects: 9

Group type: COMPARATOR
Intervention: Cycling exercise at a self-selected intensity
Number of subjects: 9

Group type: COMPARATOR
Intervention: Quiet rest
Number of subjects: 9
Study: 27476110

Group type: EXPERIMENTAL
Intervention: Affect Regulation Treatment to Enhance Methamphetamine Intervention Success (ARTEMIS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Attention-matched control condition
Number of subjects: 100
Study: 24169163

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Early parenteral nutrition (EPN)
Number of subjects: 123
Study: 22415569

Group type: EXPERIMENTAL
Intervention: 4 mg rosiglitazone daily for 12 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo daily for 12 weeks
Number of subjects: 38
Study: 20109459

Group type: EXPERIMENTAL
Intervention: Imitated participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not imitated participants
Number of subjects: 0
Study: 18604118

Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 120

Group type: COMPARATOR
Intervention: Intra-operative diagnosis
Number of subjects: 120

Group type: COMPARATOR
Intervention: Histopathological diagnosis
Number of subjects: 120
Study: 16027569

Group type: EXPERIMENTAL
Intervention: Minnesota Living With Heart Failure Questionnaire (LHFQ)
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Minnesota Living With Heart Failure Questionnaire (LHFQ) Physical subscale
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Minnesota Living With Heart Failure Questionnaire (LHFQ) Emotional subscale
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Minnesota Living With Heart Failure Questionnaire (LHFQ) after deletion of problematic items
Number of subjects: 638
Study: 11820462

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus hyperthermia (RT + HT)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Radiotherapy (RT)
Number of subjects: 114
Study: 10405677

Group type: EXPERIMENTAL
Intervention: Early postoperative enteral feeding protocol (jejunal feeding tube placed during surgery, initiated within 12 hours after surgery)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 225
Study: 7577408

Group type: EXPERIMENTAL
Intervention: rhGH 0.05 mg/kg per day subcutaneously
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 2289216

Group type: EXPERIMENTAL
Intervention: Enalapril (up to 40 mg daily)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Sustained-release diltiazem (360 mg daily)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 159

Group type: COMPARATOR
Intervention: Sustained-release diltiazem
Number of subjects: 159
Study: 6988933

Group type: EXPERIMENTAL
Intervention: Lipid-lowering diet
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 31722611

Group type: EXPERIMENTAL
Intervention: Online training resource
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 168
Study: 31122743

Group type: EXPERIMENTAL
Intervention: Non-precaution group (NPG)
Number of subjects: 394

Group type: COMPARATOR
Intervention: Precaution group (PG)
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: NPG
Number of subjects: 394

Group type: COMPARATOR
Intervention: PG
Number of subjects: 394
Study: 27094749

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (local ambassadors, management support, environmental changes, a lecture and a workshop)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention
Number of subjects: 317

Group type: COMPARATOR
Intervention: Control (behave as usual)
Number of subjects: 317
Study: 26038356

Group type: COMPARATOR
Intervention: Ibandronate (6 mg intravenous or 50 mg oral)
Number of subjects: 3474

Group type: COMPARATOR
Intervention: Ibandronate
Number of subjects: 3474
Study: 24135743

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 11

Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 11

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 11
Study: 21790680

Group type: EXPERIMENTAL
Intervention: Topical beclomethasone dipropionate (BDP) 3mg enema during radiotherapy and 2x3mg suppositories for 4 weeks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Topical beclomethasone dipropionate (BDP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 120
Study: 20175432

Group type: EXPERIMENTAL
Intervention: 6.4% CHO‐E solution
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo solution (PLA)
Number of subjects: 8
Study: 16465653

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 1353

Group type: EXPERIMENTAL
Intervention: Etanercept plus Methotrexate (MTX)
Number of subjects: 1353

Group type: COMPARATOR
Intervention: Etanercept plus MTX
Number of subjects: 1353
Study: 15024373

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate (spray or swab)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study: 11743466

Group type: EXPERIMENTAL
Intervention: Computer-based ENG system with caloric air stimulation
Number of subjects: 64
Study: 9247517

Group type: EXPERIMENTAL
Intervention: Sandbag placed over the site
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Pressure dressing constructed from surgical gauze and elastic tape
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Commercially available compression device
Number of subjects: 400

Group type: COMPARATOR
Intervention: No use of compressive dressing
Number of subjects: 400

Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 400
Study: 7973317

Group type: EXPERIMENTAL
Intervention: Normal nocturnal sleep (2300 to 0700 hours)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Shifted daytime sleep (0700 to 1500 hours)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Waking periods
Number of subjects: 7
Study: 2499524

Group type: EXPERIMENTAL
Intervention: 1,000 mg ibuprofen-lysinsalt
Number of subjects: 59

Group type: COMPARATOR
Intervention: 50 mg diclofenac
Number of subjects: 59
Study: 30947740

Group type: EXPERIMENTAL
Intervention: Humidified high-flow oxygenation via nasal cannula at 60 L/min
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-rebreather mask and standard nasal cannula at an oxygen flow rate of 15 L/min
Number of subjects: 0
Study: 26400321

Group type: EXPERIMENTAL
Intervention: Image-Guided Radiation Therapy (IGRT)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Intensity-Modulated Radiation Therapy (IMRT)
Number of subjects: 170
Study: 23902962

Group type: EXPERIMENTAL
Intervention: Grapefruit group (1.5 grapefruit/day for 6 weeks)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Grapefruit group (1.5 grapefruit/day for 6 weeks) in adults with MetS
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Grapefruit group (1.5 grapefruit/day for 6 weeks) with high baseline F2-isoprostane concentrations
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (low bioactive diet devoid of citrus)
Number of subjects: 69
Study: 21658221

Group type: EXPERIMENTAL
Intervention: Individualised eight‐week home‐based physical rehabilitation program with three physical trainer home visits and four follow‐up phone calls
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Individualised eight‐week home‐based physical rehabilitation program
Number of subjects: 195
Study: 18266537

Group type: EXPERIMENTAL
Intervention: Non-aggression-focused behavioral couple therapy
Number of subjects: 134
Study: 16365124

Group type: EXPERIMENTAL
Intervention: Immediate weight-bearing mobilisation after surgical repair
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate weight-bearing mobilisation after conservative treatment
Number of subjects: 0
Study: 14651538

Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen lysine 10 mg/kg, followed by 5 mg/kg after 24 and 48 h (n = 32)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Intravenous indomethacin 0.2 mg/kg every 12 h for three doses (n = 31)
Number of subjects: 63
Study: 10768530

Group type: EXPERIMENTAL
Intervention: Full-time splint wear instructions
Number of subjects: 21

Group type: COMPARATOR
Intervention: Night-only splint wear instructions
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Combined sample
Number of subjects: 21
Study: 8678624

Group type: EXPERIMENTAL
Intervention: CD14 expression in monocytes
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Mean fluorescence intensity (MC CD14)
Number of subjects: 213
Study: 1873206

Group type: EXPERIMENTAL
Intervention: MC903 (vitamin D3 analogue)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 15
Study: 6356902

Group type: EXPERIMENTAL
Intervention: Labetalol (100 mg twice a day)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Labetalol (400 mg twice a day, maximum dose)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 30362147

Group type: EXPERIMENTAL
Intervention: Teriflunomide sodium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leflunomide
Number of subjects: 0
Study: 29019319

Group type: EXPERIMENTAL
Intervention: Carotid Endarterectomy (CEA)
Number of subjects: 2125

Group type: COMPARATOR
Intervention: Carotid Artery Stenting (CAS)
Number of subjects: 2125
Study: 27552322

Group type: EXPERIMENTAL
Intervention: Gatekeeper training for nursing home staff
Number of subjects: 24

Group type: COMPARATOR
Intervention: No gatekeeper training for nursing home staff
Number of subjects: 24
Study: 25101576

Group type: EXPERIMENTAL
Intervention: Bioabsorbable stent implantation (BASI)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Common femoral artery endarterectomy (CFE)
Number of subjects: 80
Study: 23234082

Group type: EXPERIMENTAL
Intervention: Family Reconstruction group
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Transactional Analysis group
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Growth group
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Counseling groups
Number of subjects: 58

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 58

Group type: COMPARATOR
Intervention: Leaders and members
Number of subjects: 58
Study: 19936896

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PBPK model predictions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PBPK model with empirical scaling factor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interspecies difference in elimination rate
Number of subjects: 0
Study: 17228348

Group type: EXPERIMENTAL
Intervention: Individual counselling on diet and leisure time physical activity (LTPA) during five routine visits to a public health nurse until 37 weeks' gestation.
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard maternity care (control group).
Number of subjects: 105
Study: 15387489

Group type: EXPERIMENTAL
Intervention: Intermittent antegrade warm blood hyperkalemic cardioplegia with magnesium
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intermittent antegrade warm blood hyperkalemic cardioplegia without magnesium
Number of subjects: 20
Study: 11457629

Group type: EXPERIMENTAL
Intervention: CATCH physical education intervention
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Classroom teachers
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: PE specialists
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study: 9728822

Group type: EXPERIMENTAL
Intervention: Video intervention
Number of subjects: 127

Group type: COMPARATOR
Intervention: Nonvideo control
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Low trait anxiety scores
Number of subjects: 127
Study: 8680787

Group type: EXPERIMENTAL
Intervention: Topical application of recombinant tissue plasminogen activator (tPA) compounded in 1% hyaluronate acid (HA) at doses of 0.25, 0.5, and 1.0 mg/ml for 4 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (HA alone)
Number of subjects: 12
Study: 2805375

Group type: EXPERIMENTAL
Intervention: Local anaesthesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 100
Study: 1220835

Group type: EXPERIMENTAL
Intervention: Cytopipette (postal 'do-it-yourself' method)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional cervical scrape examination (invitation to attend a clinic or see a general practitioner)
Number of subjects: 0
Study: 29617755

Group type: EXPERIMENTAL
Intervention: Activator
Number of subjects: 60
Study: 28721886

Group type: EXPERIMENTAL
Intervention: Yoga intervention (twice-weekly classes during RT)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 68

Group type: COMPARATOR
Intervention: No-yoga control group
Number of subjects: 68
Study: 25980426

Group type: EXPERIMENTAL
Intervention: MF59-aIIV3 alone
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: MF59-aIIV3 + PPSV23 in contralateral arms
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: MF59-aIIV3 + PPSV23 in the same arm
Number of subjects: 224

Group type: COMPARATOR
Intervention: PPSV23 alone
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: PPSV23
Number of subjects: 224
Study: 23438454

Group type: EXPERIMENTAL
Intervention: HPS (HumaPen Savvio)
Number of subjects: 203

Group type: COMPARATOR
Intervention: HPL (HumaPen Luxura)
Number of subjects: 203
Study: 22024517

Group type: EXPERIMENTAL
Intervention: Tenofovir
Number of subjects: 3316

Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 3316

Group type: EXPERIMENTAL
Intervention: Nevirapine
Number of subjects: 3316

Group type: COMPARATOR
Intervention: Routine laboratory and clinical monitoring (LCM)
Number of subjects: 3316

Group type: COMPARATOR
Intervention: Clinically driven monitoring (CDM)
Number of subjects: 3316

Group type: EXPERIMENTAL
Intervention: Overall eGFR changes
Number of subjects: 3316

Group type: EXPERIMENTAL
Intervention: Overall regimens and monitoring strategies
Number of subjects: 3316
Study: 19318873

Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (IMN)
Number of subjects: 18
Study: 16306923

Group type: EXPERIMENTAL
Intervention: Mediterranean diet group (MG; n=48)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Advice-only group (AG; n=53)
Number of subjects: 101
Study: 15459142

Group type: EXPERIMENTAL
Intervention: Noninvasive pressure support ventilation (PS‐NI)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Invasive pressure support ventilation (PS‐I)
Number of subjects: 10
Study: 11068083

Group type: EXPERIMENTAL
Intervention: Family history of type 2 diabetes
Number of subjects: 189
Study: 9069004

Group type: EXPERIMENTAL
Intervention: Selective oropharyngeal decontamination (SOD) with amphotericin B, colistin sulfate, and tobramycin
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (no SOD)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Selective oropharyngeal decontamination (SOD)
Number of subjects: 88
Study: 8087579

Group type: EXPERIMENTAL
Intervention: Protocol control of ventilatory management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardized therapy via computerized protocols
Number of subjects: 0
Study: 3815140

Group type: EXPERIMENTAL
Intervention: Cefazolin (1 g intravenous injections, four doses over 12 hours)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Cefamandole (750 mg intravenous injections, four doses)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Both antibiotics
Number of subjects: 155
Study: 28700102

Group type: EXPERIMENTAL
Intervention: Microletter + short message intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phone call (control)
Number of subjects: 0
Study: 27617500

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sham taping
Number of subjects: 41
Study: 26027135

Group type: EXPERIMENTAL
Intervention: Supplementing Qi and activating blood circulation herbs (60 mL per time, 3 times a day for 14 days)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Routine treatment (control group)
Number of subjects: 67
Study: 22242558

Group type: EXPERIMENTAL
Intervention: MET/CBT with CM
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: MET/CBT without CM
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: DC with CM
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: DC without CM
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Voucher condition (general attendance)
Number of subjects: 136
Study: 20401554

Group type: EXPERIMENTAL
Intervention: Early active mobilization at 5 days (n = 13)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 4 weeks of immobilization with active motion at 29 days (n = 11)
Number of subjects: 24
Study: 18580387

Group type: EXPERIMENTAL
Intervention: Enhanced strategy (trained nurse promoting provider guideline adherence and patient compliance)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Basic educational implementation strategy
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Enhanced strategy
Number of subjects: 291
Study: 16161515

Group type: EXPERIMENTAL
Intervention: Health promotion initiative (intervention group)
Number of subjects: 835

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 835
Study: 12002707

Group type: EXPERIMENTAL
Intervention: Acetazolamide (Acz) challenged CBF SPET images
Number of subjects: 13

Group type: COMPARATOR
Intervention: Physiological saline (placebo)
Number of subjects: 13
Study: 10435606

Group type: EXPERIMENTAL
Intervention: Nalmefene (20 mg/d and 80 mg/d)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 7772078

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (50-100 mg on alternate days for 3 weeks after a loading dose of 100 mg/day for 1 week)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vehicle control (not specified)
Number of subjects: 16
Study: 2138875

Group type: EXPERIMENTAL
Intervention: Acitretin and UV-B
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo and UV-B
Number of subjects: 82
Study: 729618

Group type: EXPERIMENTAL
Intervention: Clonidine 0.3 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Tiamenidine 1.0 mg
Number of subjects: 9
Study: 30995329

Group type: EXPERIMENTAL
Intervention: Midazolam with magnesium (2 g bolus at 30 minutes, 16 mg/24-hour magnesium infusion)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Midazolam (0.03-0.3 mg/kg bolus loading dose + 0.03-0.2 mg/kg/hour infusion)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Midazolam with magnesium
Number of subjects: 50

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 50
Study: 28384091

Group type: EXPERIMENTAL
Intervention: Laid-back breastfeeding position
Number of subjects: 152

Group type: COMPARATOR
Intervention: Side-lying breastfeeding position
Number of subjects: 152
Study: 26036551

Group type: EXPERIMENTAL
Intervention: PEEP 10 mm Hg (group P)
Number of subjects: 40

Group type: COMPARATOR
Intervention: PEEP 0 cm H20 (group K)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (K and P)
Number of subjects: 40
Study: 23839667

Group type: EXPERIMENTAL
Intervention: Standard intervention (peer modeling explained through photos, video clips, and interactive tasks)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Animated intervention (similar to standard but included a monkey puppet as a cue reminder)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control condition (participants solved a puzzle with a same-sex confederate who was instructed to eat chocolate candy)
Number of subjects: 141
Study: 21632728

Group type: EXPERIMENTAL
Intervention: Illness Management and Recovery (IMR) program for nine months
Number of subjects: 41

Group type: COMPARATOR
Intervention: Treatment as usual (control condition)
Number of subjects: 41
Study: 19727982

Group type: EXPERIMENTAL
Intervention: BPD-LL with high-calcium diet, 200 IU of vitamin D, and 100 mg elemental calcium daily
Number of subjects: 26

Group type: COMPARATOR
Intervention: BPD-LL with high-calcium diet, 200 IU of vitamin D, 100 mg elemental calcium daily, and an extra 2 g of calcium
Number of subjects: 26
Study: 16703970

Group type: EXPERIMENTAL
Intervention: Interventional pain management procedures
Number of subjects: 566